| Period Ending: |
LTM
(Last Twelve Months) |
2025
(Q3)
09-30 |
2025
(Q2)
06-30 |
2025
(Q1)
03-31 |
2024
(Q4)
12-31 |
2021
(Q2)
06-30 |
2020
(Q4)
12-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-11-10 | 2025-11-10 | 2025-08-11 | 2025-03-31 | 2025-03-31 | 2021-08-17 | 2021-06-01 |
| Revenue | 444.5 | 123.3 | 91.34 | 116.5 | 113.4 | 0 | 0 |
| Cost of Revenue | 281.8 | 76.88 | 59.62 | 73.47 | 71.87 | 0 | 0 |
| Gross Profit | 162.7 | 46.41 | 31.72 | 43.02 | 41.52 | 0 | 0 |
| Operating Expenses | 115.9 | 33.42 | 15.51 | 24.08 | 42.94 | 0.544 | 0.922 |
| Research & Development | 32.5 | 7.76 | 7.72 | 8.25 | 8.77 | 0 | 0 |
| Selling, General and Administrative | 33.23 | 13.66 | 0.573 | 3.65 | 15.34 | 0 | 0 |
| Other Operating Expenses | 50.22 | 12 | 7.22 | 12.18 | 18.82 | 0.544 | 0.922 |
| Operating Income | 46.72 | 12.99 | 16.21 | 18.93 | -1.42 | -0.544 | -0.922 |
| Net Non-Operating Interest | -4.49 | -1.02 | -1.05 | -1.01 | -1.4 | 0 | 0 |
| Interest Income | 0.802 | 0.236 | 0.198 | 0.177 | 0.191 | 0 | 0 |
| Interest Expense | 5.29 | 1.25 | 1.25 | 1.19 | 1.59 | 0 | 0 |
| Equity & Other Income/(Expense) | -169.4 | -12.72 | -121 | 43.87 | -79.5 | -1.49 | 2.66 |
| Income Before Tax | -127.1 | -0.75 | -105.8 | 61.79 | -82.32 | -2.03 | 1.74 |
| Income Tax Expense | 0.959 | 0.739 | 0.22 | 0 | 0 | 0.017 | 0.367 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -128.1 | -1.49 | -106.1 | 61.79 | -82.32 | -2.05 | 1.38 |
| Depreciation and Amortization | 8.27 | 8.27 | 0 | 0 | 0 | -1.52 | 1.93 |
| EBITDA | 54.99 | 21.27 | 16.21 | 18.93 | -1.42 | -2.07 | 1.01 |
| Earnings Per Share (EPS) | -0.405 | -0.005 | -0.33 | 0.19 | -0.26 | -0.058 | 0.039 |
| Diluted Earnings Per Share | -0.545 | -0.005 | -0.33 | 0.05 | -0.26 | -0.058 | 0.039 |
| Weighted Average Shares Outstanding | 323.8 | 323.8 | 323.6 | 323.4 | 322,327 | 35.47 | 35.47 |
| Diluted Weighted Average Shares Outstanding | 323.8 | 323.8 | 323.6 | 374.4 | 322,327 | 35.47 | 35.47 |
